NEW YORK (GenomeWeb News) — Third Wave Technologies today said it has countersued Digene after the company sued Third Wave in January for allegedly infringing its human papillomavirus IP.
 
In its suit, filed with the US District Court for the Western District of Wisconsin, Third Wave claims Digene has “abused its monopoly power to thwart competition” in the HPV diagnostics market.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.